
Po-chih Chen
Examiner (ID: 15962, Phone: (571)270-7243 , Office: P/1626 )
| Most Active Art Unit | 1626 |
| Art Unit(s) | 1621, 1626 |
| Total Applications | 947 |
| Issued Applications | 619 |
| Pending Applications | 116 |
| Abandoned Applications | 237 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16525172
[patent_doc_number] => 20200399252
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-24
[patent_title] => 3-((HETERO-)ARYL)-ALKYL-8-AMINO-2-OXO-1,3-DIAZA-SPIRO-[4.5]-DECANE DERIVATIVES
[patent_app_type] => utility
[patent_app_number] => 17/007258
[patent_app_country] => US
[patent_app_date] => 2020-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30756
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 1035
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17007258
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/007258 | 3-((HETERO-)ARYL)-ALKYL-8-AMINO-2-OXO-1,3-DIAZA-SPIRO-[4.5]-DECANE DERIVATIVES | Aug 30, 2020 | Abandoned |
Array
(
[id] => 16525200
[patent_doc_number] => 20200399280
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-24
[patent_title] => 3-(Carboxymethyl)-8-Amino-2-Oxo-1,3-Diaza-Spiro-[4.5]-Decane Derivatives
[patent_app_type] => utility
[patent_app_number] => 17/007557
[patent_app_country] => US
[patent_app_date] => 2020-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33265
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 1296
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17007557
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/007557 | 3-(Carboxymethyl)-8-Amino-2-Oxo-1,3-Diaza-Spiro-[4.5]-Decane Derivatives | Aug 30, 2020 | Abandoned |
Array
(
[id] => 16525175
[patent_doc_number] => 20200399255
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-24
[patent_title] => 8-Amino-2-Oxo-1,3-Diaza-Spiro-[4.5]-Decane Derivatives
[patent_app_type] => utility
[patent_app_number] => 17/007150
[patent_app_country] => US
[patent_app_date] => 2020-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32503
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 1069
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17007150
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/007150 | 8-Amino-2-Oxo-1,3-Diaza-Spiro-[4.5]-Decane Derivatives | Aug 30, 2020 | Abandoned |
Array
(
[id] => 16525146
[patent_doc_number] => 20200399226
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-24
[patent_title] => 3-((Hetero-)Aryl)-8-Amino-2-Oxo-1,3-Diaza-Spiro-[4.5]-Decane Derivatives
[patent_app_type] => utility
[patent_app_number] => 17/007374
[patent_app_country] => US
[patent_app_date] => 2020-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26304
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -33
[patent_words_short_claim] => 1339
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17007374
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/007374 | 3-((Hetero-)Aryl)-8-Amino-2-Oxo-1,3-Diaza-Spiro-[4.5]-Decane Derivatives | Aug 30, 2020 | Abandoned |
Array
(
[id] => 16512901
[patent_doc_number] => 20200392159
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-17
[patent_title] => NOVEL RAPAMYCIN DERIVATIVES
[patent_app_type] => utility
[patent_app_number] => 17/004434
[patent_app_country] => US
[patent_app_date] => 2020-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24877
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 151
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17004434
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/004434 | NOVEL RAPAMYCIN DERIVATIVES | Aug 26, 2020 | Abandoned |
Array
(
[id] => 18172669
[patent_doc_number] => 11572366
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-07
[patent_title] => Heterocyclic compounds as immunomodulators
[patent_app_type] => utility
[patent_app_number] => 17/001129
[patent_app_country] => US
[patent_app_date] => 2020-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29257
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 1266
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17001129
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/001129 | Heterocyclic compounds as immunomodulators | Aug 23, 2020 | Issued |
Array
(
[id] => 19913759
[patent_doc_number] => 12289994
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-04-29
[patent_title] => Photoelectric conversion device and sensor and electronic device
[patent_app_type] => utility
[patent_app_number] => 16/999130
[patent_app_country] => US
[patent_app_date] => 2020-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 11847
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 182
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16999130
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/999130 | Photoelectric conversion device and sensor and electronic device | Aug 20, 2020 | Issued |
Array
(
[id] => 16483853
[patent_doc_number] => 20200377454
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-03
[patent_title] => Solid Forms Comprising An Oxime Ether Compound, Compositions and Methods of Use Thereof
[patent_app_type] => utility
[patent_app_number] => 16/996720
[patent_app_country] => US
[patent_app_date] => 2020-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 78848
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -35
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16996720
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/996720 | Solid forms comprising an oxime ether compound, compositions and methods of use thereof | Aug 17, 2020 | Issued |
Array
(
[id] => 16681653
[patent_doc_number] => 10941119
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-03-09
[patent_title] => Method for preparing imidazolin-2 ketone compound
[patent_app_type] => utility
[patent_app_number] => 16/993362
[patent_app_country] => US
[patent_app_date] => 2020-08-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3338
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16993362
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/993362 | Method for preparing imidazolin-2 ketone compound | Aug 13, 2020 | Issued |
Array
(
[id] => 16893122
[patent_doc_number] => 11034655
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2021-06-15
[patent_title] => Compounds for inhibiting the activity of SARS-COV-2 spike glycoprotein
[patent_app_type] => utility
[patent_app_number] => 16/988692
[patent_app_country] => US
[patent_app_date] => 2020-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 13
[patent_no_of_words] => 7468
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 236
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16988692
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/988692 | Compounds for inhibiting the activity of SARS-COV-2 spike glycoprotein | Aug 8, 2020 | Issued |
Array
(
[id] => 16621437
[patent_doc_number] => 20210040090
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-11
[patent_title] => SALTS OF A PD-1/PD-L1 INHIBITOR
[patent_app_type] => utility
[patent_app_number] => 16/987557
[patent_app_country] => US
[patent_app_date] => 2020-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19067
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -34
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16987557
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/987557 | Salts of a PD-1/PD-L1 inhibitor | Aug 6, 2020 | Issued |
Array
(
[id] => 16621394
[patent_doc_number] => 20210040047
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-11
[patent_title] => NOVEL PIPERAZINE AND PIPERIDINE DERIVATIVES, THEIR SYNTHESIS AND USE THEREOF IN INHIBITING VDAC OLIGOMERIZATION, APOPTOSIS AND MITOCHONDRIA DYSFUNCTION
[patent_app_type] => utility
[patent_app_number] => 16/947557
[patent_app_country] => US
[patent_app_date] => 2020-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18197
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 294
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16947557
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/947557 | Piperazine and piperidine derivatives, their synthesis and use thereof in inhibiting VDAC oligomerization, apoptosis and mitochondria dysfunction | Aug 5, 2020 | Issued |
Array
(
[id] => 17851823
[patent_doc_number] => 20220281865
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-08
[patent_title] => DIHYDROPYRIMIDINE DERIVATIVES AND USES THEREOF IN THE TREATMENT OF HBV INFECTION OR OF HBV-INDUCED DISEASES
[patent_app_type] => utility
[patent_app_number] => 17/597894
[patent_app_country] => US
[patent_app_date] => 2020-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19624
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17597894
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/597894 | DIHYDROPYRIMIDINE DERIVATIVES AND USES THEREOF IN THE TREATMENT OF HBV INFECTION OR OF HBV-INDUCED DISEASES | Jul 29, 2020 | Abandoned |
Array
(
[id] => 17587668
[patent_doc_number] => 11325924
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-05-10
[patent_title] => Modulators of Sestrin-GATOR2 interaction and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/941821
[patent_app_country] => US
[patent_app_date] => 2020-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40430
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16941821
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/941821 | Modulators of Sestrin-GATOR2 interaction and uses thereof | Jul 28, 2020 | Issued |
Array
(
[id] => 17835700
[patent_doc_number] => 20220273005
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-01
[patent_title] => METHOD OF INDUCING BACTERIAL HEAT SENSITIVITY
[patent_app_type] => utility
[patent_app_number] => 17/627799
[patent_app_country] => US
[patent_app_date] => 2020-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11461
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17627799
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/627799 | METHOD OF INDUCING BACTERIAL HEAT SENSITIVITY | Jul 15, 2020 | Abandoned |
Array
(
[id] => 16436993
[patent_doc_number] => 20200354319
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-12
[patent_title] => MONOMERS CAPABLE OF DIMERIZING IN AN AQUEOUS SOLUTION, AND METHODS OF USING SAME
[patent_app_type] => utility
[patent_app_number] => 16/929528
[patent_app_country] => US
[patent_app_date] => 2020-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 76364
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16929528
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/929528 | Monomers capable of dimerizing in an aqueous solution, and methods of using same | Jul 14, 2020 | Issued |
Array
(
[id] => 17851789
[patent_doc_number] => 20220281831
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-08
[patent_title] => FUSED-GLUTARIMIDE CRBN LIGANDS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/597628
[patent_app_country] => US
[patent_app_date] => 2020-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 73995
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17597628
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/597628 | FUSED-GLUTARIMIDE CRBN LIGANDS AND USES THEREOF | Jul 14, 2020 | Pending |
Array
(
[id] => 17988799
[patent_doc_number] => 20220354836
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-10
[patent_title] => Equine Esomeprazole Formulations and Methods of Use
[patent_app_type] => utility
[patent_app_number] => 17/626936
[patent_app_country] => US
[patent_app_date] => 2020-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18436
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -87
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17626936
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/626936 | Equine Esomeprazole Formulations and Methods of Use | Jul 14, 2020 | Pending |
Array
(
[id] => 16390927
[patent_doc_number] => 20200331868
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-22
[patent_title] => COMPOUND AS PPAR AGONIST AND APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/921102
[patent_app_country] => US
[patent_app_date] => 2020-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24619
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16921102
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/921102 | Compound as PPAR agonist and application thereof | Jul 5, 2020 | Issued |
Array
(
[id] => 17913163
[patent_doc_number] => 20220315558
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-06
[patent_title] => POLYMORPHS OF 1-(2-((((TRANS)-3-FLUORO-1-(3-FLUOROPYRIDIN-2-YL)CYCLOBUTYL)METHYL)AMINO)PYRIMIDIN-5-YL)-1H-PYRROLE-3-CARBOXAMIDE
[patent_app_type] => utility
[patent_app_number] => 17/621950
[patent_app_country] => US
[patent_app_date] => 2020-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16998
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -41
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17621950
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/621950 | POLYMORPHS OF 1-(2-((((TRANS)-3-FLUORO-1-(3-FLUOROPYRIDIN-2-YL)CYCLOBUTYL)METHYL)AMINO)PYRIMIDIN-5-YL)-1H-PYRROLE-3-CARBOXAMIDE | Jun 25, 2020 | Abandoned |